Kissei Pharmaceutical has been growing earnings at an average annual rate of 12%, while the Pharmaceuticals industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 8.1% per year. Kissei Pharmaceutical's return on equity is 6%, and it has net margins of 14.1%.
Key information
12.01%
Earnings growth rate
14.20%
EPS growth rate
Pharmaceuticals Industry Growth
5.95%
Revenue growth rate
8.13%
Return on equity
6.03%
Net Margin
14.15%
Last Earnings Update
31 Mar 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Kissei Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:KSPH.F Revenue, expenses and earnings (JPY Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
97,406
13,779
48,745
0
31 Dec 25
95,294
14,135
48,085
0
30 Sep 25
91,695
14,496
32,088
12,889
30 Jun 25
89,357
12,374
38,539
0
31 Mar 25
88,330
11,961
22,179
12,889
31 Dec 24
83,389
11,663
37,804
0
30 Sep 24
81,067
10,731
24,122
9,474
30 Jun 24
77,430
12,001
34,098
0
31 Mar 24
75,579
11,160
20,790
9,474
31 Dec 23
73,717
12,198
19,797
10,391
30 Sep 23
71,607
12,880
19,763
10,391
30 Jun 23
70,521
12,158
20,234
10,391
31 Mar 23
67,493
10,528
20,304
10,391
31 Dec 22
66,931
12,769
20,428
10,363
30 Sep 22
65,857
10,581
21,555
10,363
30 Jun 22
65,031
10,912
20,369
10,363
31 Mar 22
65,381
12,921
19,923
10,363
31 Dec 21
66,934
5,664
21,682
9,626
30 Sep 21
69,148
6,555
20,749
9,626
30 Jun 21
69,618
7,204
20,555
9,626
31 Mar 21
69,044
5,285
19,607
9,626
31 Dec 20
66,877
5,715
18,400
10,767
30 Sep 20
63,970
5,063
18,820
10,767
30 Jun 20
63,196
2,530
19,774
10,767
31 Mar 20
63,234
2,817
21,133
10,767
31 Dec 19
65,594
4,753
17,519
15,711
30 Sep 19
68,180
4,294
21,036
15,711
30 Jun 19
70,545
4,752
22,088
15,711
31 Mar 19
72,297
5,481
22,577
15,711
31 Dec 18
72,474
5,263
24,217
14,179
30 Sep 18
73,087
8,102
20,844
14,179
30 Jun 18
73,014
9,685
20,770
14,179
31 Mar 18
74,009
9,045
23,080
14,179
31 Dec 17
73,887
8,735
24,178
13,877
30 Sep 17
72,459
8,116
24,749
13,877
30 Jun 17
71,396
6,993
25,151
13,877
31 Mar 17
71,706
7,726
23,379
13,877
31 Dec 16
72,154
6,401
25,193
14,106
30 Sep 16
73,533
8,108
23,515
14,106
30 Jun 16
73,774
8,734
22,456
14,106
31 Mar 16
71,294
8,165
22,528
14,106
31 Dec 15
71,239
8,521
21,788
14,488
30 Sep 15
69,095
6,608
22,543
14,488
30 Jun 15
70,945
7,161
23,406
14,488
Quality Earnings: KSPH.F has a large one-off gain of ¥18.4B impacting its last 12 months of financial results to 31st March, 2026.
Growing Profit Margin: KSPH.F's current net profit margins (14.1%) are higher than last year (13.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: KSPH.F's earnings have grown by 12% per year over the past 5 years.
Accelerating Growth: KSPH.F's earnings growth over the past year (15.2%) exceeds its 5-year average (12% per year).
Earnings vs Industry: KSPH.F earnings growth over the past year (15.2%) exceeded the Pharmaceuticals industry -5%.
Return on Equity
High ROE: KSPH.F's Return on Equity (6%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/22 09:30
End of Day Share Price
2026/03/13 00:00
Earnings
2026/03/31
Annual Earnings
2026/03/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Kissei Pharmaceutical Co., Ltd. is covered by 16 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.